Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2015 | Design and results of PERSIST-1 trial of pacritinib for myelofibrosis

Dr Ruben A. Mesa discusses the design and results of the phase 3 PERSIST- trial of pacritinib for patients with myelofibrosis.